Pharmaceuticals

Global Orthopedic Biomaterials Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-19189546 | Published Date: 22-Sep-2021 | No. of pages: 112

Description

The Orthopedic Biomaterials market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Orthopedic Biomaterials market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Orthopedic Biomaterials Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Orthopedic Biomaterials market are:
Victrex PLC (Invibio Ltd.)
Koninklijke DSM N.V. (DSM Biomedical B.V.)
Evonik Industries AG
Stryker Corporation
Exactech Inc.
Collagen Matrix Inc.
CAM Bioceramics B.V.
Heraeus Holding GmbH
Zimmer Biomet Holdings Inc.
Globus Medical Inc.

Most important types of Orthopedic Biomaterials products covered in this report are:
Ceramics & Bioactive Glasses
Calcium Phosphate Cements
Polymers
Metal
Composites

Most widely used downstream fields of Orthopedic Biomaterials market covered in this report are:
Orthopedic Implants
Joint Replacements
Bio-resorbable Tissue Fixation
Orthobiologics
Visco Supplementation

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.